Showing results (31-40 of 238) with videos related to
Sort By:
Pageof 24
Hematology/Oncology Clinics of North America|November 19, 2011
Prognostic factors in adult acute leukemiaChezi Ganzel, Jacob M RoweBlood|April 18, 2013
Gemtuzumab ozogamicin in acute myeloid leukemia: a remarkable saga about an active drugJacob M Rowe, Bob LöwenbergCurrent Opinion in Hematology|January 10, 2012
Treatment for relapsed acute myeloid leukemia: what is new?Yishai Ofran, Jacob M RoweCurrent Opinion in Hematology|December 27, 2018
Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemiaTsila Zuckerman, Jacob M RoweCurrent Opinion in Hematology|January 10, 2015
Introducing minimal residual disease in acute myeloid leukemiaYishai Ofran, Jacob M RoweF1000Prime Reports|September 4, 2014
Pathogenesis and prognostication in acute lymphoblastic leukemiaTsila Zuckerman, Jacob M RoweActa Haematologica|September 18, 2014
Acute myeloid leukemia in adolescents and young adults: challenging aspectsYishai Ofran, Jacob M RoweExpert Opinion on Biological Therapy|November 3, 2017
Inotuzumab ozogamicin for the treatment of acute lymphoblastic leukemiaAriella Tvito, Jacob M RoweCurrent Opinion in Hematology|January 27, 2007
Alternative donor transplantation in acute myeloid leukemia: which source and when?Tsila Zuckerman, Jacob M RoweClinical Reviews in Allergy & Immunology|May 20, 2009
Hematopoetic stem cell transplantation in neutrophil disorders: severe congenital neutropenia, leukocyte adhesion deficiency and chronic granulomatous diseaseRonit Elhasid, Jacob M RowePageof 24